PDCD1 and Autoimmunity: The onset of T1D induced in some individuals treated with ICI (i.e., anti-PD-1 mAb) indicates that a failure of these control mechanisms could be one of the mechanisms leading to β cell autoimmunity also in patients with “classical” T1D.